highly significantp < 0.0001
This pathway was predicted to be downregulated in samples from MRD + patients with a highly significant Benjamini-Hochberg p-value ( p < 0.0001, z-score − 6.245; Fig. 1 C).
This pathway was predicted to be downregulated in samples from MRD + patients with a highly significant Benjamini-Hochberg p-value ( p < 0.0001, z-score − 6.245; Fig. 1 C).